59 related articles for article (PubMed ID: 6294738)
1. Comparative value of bone scintigraphy and radiography in monitoring tumor response in systemically treated prostatic carcinoma.
Levenson RM; Sauerbrunn BJ; Bates HR; Newman RD; Eddy JL; Ihde DC
Radiology; 1983 Feb; 146(2):513-8. PubMed ID: 6294738
[TBL] [Abstract][Full Text] [Related]
2. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
Pollen JJ; Witztum KF; Ashburn WL
AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
[TBL] [Abstract][Full Text] [Related]
3. Small cell lung cancer: radionuclide bone scans for assessment of tumor extent and response.
Levenson RM; Sauerbrunn BJ; Ihde DC; Bunn PA; Cohen MH; Minna JD
AJR Am J Roentgenol; 1981 Jul; 137(1):31-5. PubMed ID: 6264774
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer presenting with normal serum PSA levels and boney metastases treated with zoledronic acid.
Mystakidou K; Katsouda E; Parpa E; Vlahos L
J Pain Palliat Care Pharmacother; 2005; 19(3):41-5. PubMed ID: 16219610
[TBL] [Abstract][Full Text] [Related]
5. [Skeletal scintigraphy for the observation of course and treatment of carcinoma of the prostate ].
Pabst HW; Langhammer H; Schmid L; Sintermann R
Rofo; 1981 Jul; 135(1):44-9. PubMed ID: 6288532
[TBL] [Abstract][Full Text] [Related]
6. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
[TBL] [Abstract][Full Text] [Related]
7. The bone scan as a tumour marker in prostatic carcinoma.
Chisholm GD; Stone AR; Beynon LL; Merrick MV
Eur Urol; 1982; 8(5):257-60. PubMed ID: 6288389
[TBL] [Abstract][Full Text] [Related]
8. Flare on bone scintigraphy following Taxol chemotherapy for metastatic breast cancer.
Schneider JA; Divgi CR; Scott AM; Macapinlac HA; Seidman AD; Goldsmith SJ; Larson SM
J Nucl Med; 1994 Nov; 35(11):1748-52. PubMed ID: 7525900
[TBL] [Abstract][Full Text] [Related]
9. Bone scintigraphy in plasma-cell myeloma. A prospective study of 70 patients.
Bataille R; Chevalier J; Rossi M; Sany J
Radiology; 1982 Dec; 145(3):801-4. PubMed ID: 6292996
[TBL] [Abstract][Full Text] [Related]
10. Metastatic prostatic pulmonary nodules with normal bone image.
Petras AF; Wollett FC
J Nucl Med; 1983 Nov; 24(11):1026-7. PubMed ID: 6226768
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m labeled agents for skeletal imaging.
Thrall JH
CRC Crit Rev Clin Radiol Nucl Med; 1976; 8(1):1-31. PubMed ID: 789010
[TBL] [Abstract][Full Text] [Related]
12. [Bone scintigraphy with 99m Tc pyrophosphate in neurology].
Oberson R
Schweiz Med Wochenschr; 1975 Feb; 105(5):140-5. PubMed ID: 164688
[TBL] [Abstract][Full Text] [Related]
13. The use of serial bone scans in assessing response of bone metastases to systemic treatment.
Citrin DL; Hougen C; Zweibel W; Schlise S; Pruitt B; Ershler W; Davis TE; Harberg J; Cohen AI
Cancer; 1981 Feb; 47(4):680-5. PubMed ID: 6261915
[TBL] [Abstract][Full Text] [Related]
14. Nuclear bone imaging in metastatic cancer of the prostate.
Pollen JJ; Gerber K; Ashburn WL; Schmidt JD
Cancer; 1981 Jun; 47(11):2585-94. PubMed ID: 6266636
[No Abstract] [Full Text] [Related]
15. Quantitative bone scan and bone metastases in prostatic cancer.
Grob JC; Thiel J; Méthlin G; Wolf P; Bollack C
Urol Int; 1985; 40(1):45-7. PubMed ID: 3156441
[TBL] [Abstract][Full Text] [Related]
16. How significant are serial bone scans in monitoring advanced prostatic cancer?
Tekgül S; Ozen H; Ozyavuz R; Bakkaloğlu M; Remzi D
Int Urol Nephrol; 1995; 27(1):87-91. PubMed ID: 7615375
[TBL] [Abstract][Full Text] [Related]
17. [Significance of skeletal scintigraphy for oncological practice].
Kampmann H; Buchelt L
Rontgenblatter; 1983 Oct; 36(10):342-51. PubMed ID: 6227979
[TBL] [Abstract][Full Text] [Related]
18. The indications for and limitations of bone scintigraphy in osteogenic sarcoma: a review of 55 patients.
McKillop JH; Etcubanas E; Goris ML
Cancer; 1981 Sep; 48(5):1133-8. PubMed ID: 6268278
[TBL] [Abstract][Full Text] [Related]
19. The role of routine followup bone scans after definitive therapy of localized prostatic cancer.
Huben RP; Schellhammer PF
J Urol; 1982 Sep; 128(3):510-2. PubMed ID: 6214643
[TBL] [Abstract][Full Text] [Related]
20. [Radionuclide diagnosis and therapy of skeletal metastases of prostatic cancer].
Schümichen C
Radiologe; 1984 Jan; 24(1):13-8. PubMed ID: 6200897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
